Passage-delaying microbeads for controlled delivery of loratadine

PDA Journal of Pharmaceutical Science and Technology

Volumn 62, Issue 6, 2008, Pages 421-428

  Mishra, Shashi Kiran ^a   Philip, Anil K ^a   Pathak, Kamla ^a  

^a NH 2   (India)

Author keywords

Ethylcellulose coating; Factorial design; Loratadine; Passage delay; Zero order release

Indexed keywords

ALGINIC ACID; BUFFER; CALCIUM CHLORIDE; CASEIN; CASTOR OIL; ETHYL CELLULOSE; LORATADINE; MINERAL OIL; OIL; POLYMER;

ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG SOLUBILITY; DRUG STABILITY; EMULSION; FACTORIAL DESIGN; GELATION; IN VITRO STUDY; MEAN RESIDENCE TIME; PH; PROCESS OPTIMIZATION; STOMACH MUCOSA; SUSTAINED DRUG RELEASE;

CALORIMETRY, DIFFERENTIAL SCANNING; DELAYED-ACTION PREPARATIONS; HYDROGEN-ION CONCENTRATION; LORATADINE; MICROSPHERES; SOLUBILITY;

EID: 59349094488     PISSN: 10797440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Singh, B. N.; Kim, K. H. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J. Control. Rel. 2000, 63, 235-259.
2. Deshpande, A. A.; Rhodes, C. T.; Shah, N. H. Controlled release drug delivery systems for prolonged gastric residence: an overview. Drug Dev. Ind. Pharm. 1996, 22 (6): 531-539.
3. Dosage Form Design, 1st ed.; Ali, J., Ahuja, A., Khar, R. K., Eds.; Birla Publications: New Delhi, 2005; pp 168-229.
4. Arora, S.; Ahuja, A.; Khar, R. K.; Baboota, S. Floating drug delivery system: A review. AAPS PharmSciTech 2005, E372-E390.
5. Caldwell, L. J.; Gardner, C. R.; Cargill, R. C. Drug Delivery Device Which Can Be Retained in the Stomach for a Controlled Period of Time. U.S. Patent 4,735,804, April 5, 1988.
6. Reddy, L. H.; Murthy, R. S. Floating dosage systems in drug delivery. Crit. Rev. Ther. Drug Carr. Syst. 2002, 19 (6): 553-585.
7. Goodman & Giliman's The Pharmacological basis of Therapeutics, 10th ed.; Hardman, J. G., Limbird, L. E., Eds.; McGraw-Hill: New York, p 653.
8. Bulgarelli, E.; Forni, F.; Bernabei, M. J. Effect of matrix composition and conditions on casein gelatin beads floating properties. Int. J. Pharm. 2000, 198 (2), 157-165.
9. Cooreman, M. P.; Krausgrill, P.; Hengels, K. J. Local gastric and serum amoxycillin concentrations after different oral application forms. Antimicrob. Agents Chemother. 1993, 37 (7), 1506-1509.
10. Gohel, M. C.; Mehta, P. R.; Dave, R. K.; Bariya, N. H. A more relevant dissolution method for evaluation of floating drug delivery system. Dis-solution Technol. 2004, Nov., 22-25.
11. Sriamornsak, P.; Thirawong, N.; Puttipipatkhachorn, S. Morphology and buoyancy of oil entrapped calcium pectinate gel beads. AAPS PharmSciTech 2004, 6, 24-31, Article 24.
12. Feldman, M.; Barnett, C. Fasting gastric pH and its relationship to true hypochlorhydria in humans. Dig. Dis. Sci. 1991, 36 (7), 866-869.
13. Streubel, A.; Siepmann, J.; Bodmeier, R. Floating microparticles based on low density foam powder. Int. J. Pharm. 2002, 241 (2), 279-292.
14. Al-Saidan, S. M.; Krishanaiah, Y. S. R.; Satyanarayana, V.; Bhaskar, P.; Kartikeyan, R. S. A three-layer guar gum matrix tablet for oral controlled delivery of highly soluble metoprolol tartarate. Eur. J. Pharm. Biopharm. 2004, 58, 697-703.